Stocks of the Hour: Telix Pharmaceuticals, Hotel Property Investments & Calix

Company News

by Lauren Evans

Telix Pharmaceuticals (ASX:TLX) will contribute to a US therapy trial designed to treat prostate cancer. Telix will supply its prostate imaging product to Amgen study. Shares in Telix Pharmaceuticals (ASX:TLX) are trading 0.6 per cent higher at $6.91.

Hotel Property Investments (ASX:HPI) has raised $50 million to partially fund two acquisitions, with one still subject to approval. It also plans to pay its major tenant $38.8 million to modify leases. Shares in Hotel Property Investments (ASX:HPI) are trading 4.7 per cent lower at $3.38.

Calix (ASX:CXL) is selling a $24.5 million stake in its LEILAC business to a global decarbonisation investment group. Calix will use the funds to develop lime and cement decarbonisation technology. Shares in Calix (ASX:CXL) are trading 37.3 per cent higher at $5.26.

Click on the ASX code for the full story.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.